Aligos Therapeutics
ALGS
ALGS
48 hedge funds and large institutions have $16.6M invested in Aligos Therapeutics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
63% less capital invested
Capital invested by funds: $45.3M → $16.6M (-$28.7M)
Holders
48
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$887K | |
| 2 | +$425K | |
| 3 | +$204K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$186K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$175K |
Top Sellers
| 1 | -$302K | |
| 2 | -$168K | |
| 3 | -$130K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$116K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$90.2K |